IMS Micronizzazioni is a leading provider of custom micronisation services that transform raw materials into ultra‐fine powders for pharmaceutical, nutraceutical, and excipient applications. With over 50 years of industry expertise, our state-of-the-art processes ensure optimal product performance and enhanced bioavailability.
We deliver tailored solutions that meet stringent good manufacturing practice (GMP) standards and international regulatory requirements, empowering our clients with innovative, scalable technologies for superior product development.
Custom micronisation for pharmaceutical innovation
At IMS, our advanced micronisation process reduces particle sizes to below 5μm, ensuring your active ingredients and excipients achieve the precise granulometry required for cutting-edge drug formulations. Our custom-made services are designed to address the unique needs of human and veterinary pharmaceuticals and nutraceuticals.
By leveraging the latest milling technologies, we guarantee reproducible quality and optimal performance to improve product dissolution and therapeutic efficacy. This commitment to precision and innovation positions IMS as a trusted partner for companies seeking to enhance formulation efficiency and market competitiveness.
State-of-the-art production and processing facilities
IMS’ modern production facility features 14 ISO 7 cleanrooms designed to support high-precision operations. Each dedicated chamber – whether for steroid products, research and development, or multipurpose applications – is maintained under rigorous GMP standards to ensure absolute process integrity and product safety.
An advanced heating, ventilation and air conditioning (HVAC) system, complete with dedicated air inlets, independent conditioning groups, and multi-stage filtration (including EU14 HEPA filters), creates an environment that minimises cross-contamination while optimising air quality and temperature control. In addition, our expansive warehouse is carefully organised to segregate materials and maintain strict quality protocols, while our fully equipped laboratory supports continuous process monitoring and equipment requalification.
Utilising an extensive array of precision equipment – from multiple jetmills and high-performance mills to vibrating sieves and granulators – IMS can process batch sizes ranging from grams to tonnes. Engineered in high-grade AISI 316 steel, our machinery meets both pharmaceutical and food safety standards, providing the versatility needed to produce powders with granulometries tailored from above 200μm to below 5μm. This technological process ensures that every production run delivers consistent, high-quality results that meet even the most demanding industry specifications.
Uncompromising quality and regulatory compliance
Quality and safety are at the heart of every process at IMS. Our operations comply with all applicable GMP regulations and are continuously monitored through rigorous testing and preventive maintenance programmes.
We are proud to hold authorisations from the Italian Ministry of Health, AIFA, FDA, the Japanese PMDA, and the Korean FDA, ensuring that our products meet international standards of excellence. Every step – from the initial feasibility study to the final product release – is managed by an integrated quality system designed to mitigate risk and optimise efficiency. This unwavering dedication to quality reinforces our reputation as a leader in the highly competitive pharmaceutical market.
Dedicated team and R&D-driven expertise
IMS’ success is powered by a skilled team of technicians and specialists who continuously pursue excellence through training and innovation. Collaborating with leading universities and industry associations, our experts ensure that we remain at the forefront of micronisation technology and process optimisation.
Our in-house research and development (R&D) laboratory is outfitted with cutting-edge instruments—such as laser granulometers, differential scanning calorimeters (DSCs), thermogravimetric analyses (TGAs), and advanced optical systems—to support a wide range of services, including analytical method development, solid form studies, and comprehensive feasibility assessments. These R&D capabilities, combined with personalised consultancy services, enable us to tailor solutions that drive product innovation and facilitate seamless scale-up from laboratory to full production.
About IMS
Founded in 1973 by Salvatore Marangoni in Milan, IMS began as a chemical-pharmaceutical enterprise before evolving into a specialised micronisation service provider. Over the decades, we have continuously expanded and modernised our facilities—from synthesising active ingredients to dedicating our entire plant to precision micronisation.
Key milestones we have reached include obtaining UNI ISO 9001 certification in 2004, receiving US Food and Drug Administration (FDA) approval in 2005, and securing accreditations from both the Japanese PMDA and the Korean FDA. This ongoing commitment to innovation, quality, and customer satisfaction has established IMS as a trusted partner in the global pharmaceutical industry.
To learn how IMS’ advanced micronisation services can transform your product development and enhance bioavailability, please get in touch with our expert team. Use the contact form on this page or call us directly for a personalised consultation. We look forward to partnering with you to drive innovation and success in your pharmaceutical and nutraceutical projects.
